Report highlights personalized medicines ensuring greater efficacy for rare diseases and previously untreatable conditions Promising therapeutic developments for HIV, Parkinson’s disease, Crohn’s disease, alopecia, multiple myeloma and breast cancer on …
We challenge the status quo, pursuing continuous performance improvements, aiming for greatness and customer delight in all we do. We are a trusted, indispensable global partner to our customers, including universities, nonprofits, funding organizations, publishers, corporations, government organizations and law firms.
Let's stay in touch. Subscribe to our latest announcements.